The Republic of Iceland – Government Debt Management
| Series | RIKB 28 1115 | RIKS 30 0701 |
| ISIN | IS0000028249 | IS0000020576 |
| Maturity Date | 11/15/2028 | 07/01/2030 |
| Auction Date | 02/19/2021 | 02/19/2021 |
| Settlement Date | 02/24/2021 | 02/24/2021 |
| 10% addition | 02/23/2021 | 02/23/2021 |
On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to purchase an additional 10%.
Further reference is made to the description of the Treasury bond and the General Terms of Auction for Treasury bonds on the Government Debt Management website.
For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
BitMEX8.1.2026 14:11:00 CET | Press release
CORRECTING and REPLACING – BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
Meltwater8.1.2026 14:00:00 CET | Press release
Meltwater Achieves SOC 2 Type II Certification, Reinforcing Commitment to Data Security and Trust
Skyharbour Resources Ltd8.1.2026 14:00:00 CET | Press release
Skyharbour Announces Additional Uranium Property Staking Increasing Total Portfolio to Over 662,000 Hectares in the Athabasca Basin, Saskatchewan
MoonLake Immunotherapeutics AG8.1.2026 14:00:00 CET | Press release
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
Orion Oyj8.1.2026 14:00:00 CET | Press release
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
